COVID-19: Robotics may help to reduce exposure to virus patients during interventional procedures

Jon George Studies have shown that robotic percutaneous coronary intervention (PCI) with the CorPath GRX System (Corindus, now part of Siemens Healthineers)—compared with manual PCI—reduces radiation exposure to the cath lab staff and may also improve precision. Furthermore, during the current pandemic, it potentially could help to reduce contact with COVID-19 patients [...]

COVID-19: Optimising heart failure management in the patient’s home

Michael Kiernan Physicians recognised the importance of remote management for heart failure patients long before the COVID-19 pandemic. However, the current situation has heightened the urgency of the transition for this vulnerable population. In this commentary, Michael Kiernan reviews how remote monitoring of heart failure patients could help to reduce heart failure [...]

2020-04-16T13:55:20+00:00April 16th, 2020|Tags: , , |

Hyperbaric oxygen therapy could be a tool for encouraging cognitive recovery after stroke

Stroke is the second leading cause of mortality and the third leading cause of adult disability in the USA, causing severe long-term impairments in the lives of survivors. While the two kinds of stroke—ischaemic (85%) and haemorrhagic (15%)—differ in their origins, both culminate in compromised blood supply and subsequent brain ischaemia. This results in [...]

2020-04-03T15:41:54+00:00April 2nd, 2020|Tags: , , |

Selective endovascular cooling with TwinFlo catheter shows promise for neuroprotection in stroke patients

Ron Solar Ron Solar (ThermopeutiX, San Diego, USA) and colleagues report in EuroIntervention that the TwinFlo catheter (ThermopeutiX), in pigs, was associated with rapid, selective, deep cerebral hypothermia. They add that the catheter may “offer an improved method for neuroprotection during neurosurgery, cardiac arrest, acute stroke, and other ischaemic insult”. Solar talks [...]

2020-03-27T16:30:27+00:00March 27th, 2020|Tags: , , |

Approval of Tendyne TMVI device means physicians now have a portfolio of options for treating mitral regurgitation

In January this year, Abbott made history when it became the first company in the world to receive market approval for a transcatheter mitral valve implantation (TMVI) device. Its Tendyne system now has a CE-mark indication for the management of patients with mitral regurgitation who cannot undergo mitral valve surgery or percutaneous edge-to-edge repair [...]

2020-03-05T10:17:44+00:00March 5th, 2020|Tags: , , |

“Soft” robotic heart could be answer to donor heart shortage

Jolanda Kluin (Credit: BHF) A soft robotic heart that is designed to replace the need for a heart transplant is one of four research projects that have made the shortlist for the Big Beat Challenge initiative—organised by the British Heart Foundation—that awards £30m to a project that seeks to identify a real-world [...]

2020-02-27T13:52:36+00:00February 27th, 2020|Tags: , , |

Novel device “safely obliterates” left atrial appendage with minimal amount left behind

Leonid Sternik Append Medical, with their novel left atrial appendage (LAA) closure device (Appligator), were a finalist in the 2019 ICI Innovation Award Competition (Innovation in Cardiovascular Interventions 2019; 8–10 December, Tel Aviv, Israel). In this commentary, Leonid Sternik who came up with the concept for the device, outlines the need for [...]

2020-02-27T14:14:28+00:00February 27th, 2020|Tags: , |

“Our goal is to treat more patients with mitral regurgitation”

Patrick M McCarthy Last month, Abbott announced that that the FDA has approved a new trial—REPAIR MR—to evaluate the safety and efficacy of percutaneous edge-to-edge repair (MitraClip) for the management of patients with primary mitral regurgitation at moderate surgical risk. Currently, in both Europe and the USA, MitraClip has market approval for [...]

2020-02-10T13:21:31+00:00February 10th, 2020|Tags: , , |

Gore’s AR app helps facilitate conversations between physicians and patients

Mark Peretti Gore’s augmented reality (AR) experience app, which is available on both Apple and Android platforms, provides interactive 3D holograms of the company’s endovascular devices, such as the Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis, and is designed to be used as a high-res, anatomically correct visual aid that can be [...]

2020-02-05T12:27:08+00:00February 5th, 2020|Tags: , |

AI and its growing role in arrhythmia

Malcolm Finlay Johnny, a 72-year-old film producer, is meeting clients when his watch gently vibrates notifying him of his irregular pulse. He pressed his finger to his strap, and with a swipe sends the single lead ECG to his cardiologist without pausing the meeting. The artificial intelligence (AI) delivered backbone powering self-diagnostics [...]

2020-01-15T15:55:37+00:00January 15th, 2020|Tags: , , |

Rat study provides support for novel approach to cardiac pacing

Julian Paton Erin O’Callaghan (School of Physiology, Pharmacology and Neuroscience, Biomedical Science, University of Bristol, Bristol, UK) and others report in the Journal of Physiology that enhancing respiratory sinus arrhythmia (RSA) improved cardiac function in rats with induced heart failure. They note that this finding gives a “tantalising demonstration of the physiological [...]

2019-12-16T14:54:30+00:00December 16th, 2019|Tags: |

Apple Watch could be used to record a quasi-standard ECG

Miguel Angel Cobos Gil Miguel Angel Cobos Gil (Instituto Cardiovascular, Hospital Clinico San Carlos, Madrid, Spain) outlines in Annals of Internal Medicine a novel method of using the Apple Watch to record a multilead, quasi-standard ECG. He reports that the method is feasible but that a “broad range of clinical studies are [...]

2019-12-16T14:50:11+00:00December 16th, 2019|Tags: |

EACTS 2019: Techno-College Innovation Award for LifeMatrix bioengineering platform

Max Y Emmert At the 2019 European Association of Cardio-Thoracic Surgeons (EACTS) annual meeting (3–5 October, Lisbon, Portual), Max Y Emmert (Institute for Regenerative Medicine, University of Zurich, Switzerland/the Department for Cardiothoracic and Vascular Surgery, German Heart Center Berlin and Charite Berlin, Germany) received the Techno-College Innovation Award for the LifeMatrix, a [...]

2019-12-10T19:39:22+00:00December 6th, 2019|Tags: , |

Further innovation and research is required for thrombus aspiration in PCI

S Jay Mathews The TASTE and TOTAL studies suggested that routine thombus aspiration in patients undergoing percutaneous coronary intervention (PCI) did not provide mortality benefit and may increase the risk of stroke. However, a new study (CHEETAH) is evaluating whether a next-generation aspiration catheter could lead to improved outcomes. S Jay Mathews [...]

2019-11-21T09:38:40+00:00November 20th, 2019|Tags: , , |